nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.287	0.315	CbGbCtD
Thioridazine—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.241	0.264	CbGbCtD
Thioridazine—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.2	0.22	CbGbCtD
Thioridazine—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.183	0.201	CbGbCtD
Thioridazine—HTR2A—arteriole—focal segmental glomerulosclerosis	0.00262	0.392	CbGeAlD
Thioridazine—HTR7—endothelium—focal segmental glomerulosclerosis	0.000861	0.129	CbGeAlD
Thioridazine—Acepromazine—ALB—focal segmental glomerulosclerosis	0.000684	0.193	CrCbGaD
Thioridazine—Thioproperazine—ALB—focal segmental glomerulosclerosis	0.000669	0.189	CrCbGaD
Thioridazine—Thiothixene—ALB—focal segmental glomerulosclerosis	0.000658	0.186	CrCbGaD
Thioridazine—Pipotiazine—ALB—focal segmental glomerulosclerosis	0.000658	0.186	CrCbGaD
Thioridazine—ADRA1B—kidney—focal segmental glomerulosclerosis	0.000595	0.089	CbGeAlD
Thioridazine—HTR2A—endothelium—focal segmental glomerulosclerosis	0.000537	0.0803	CbGeAlD
Thioridazine—Clomipramine—ALB—focal segmental glomerulosclerosis	0.00052	0.147	CrCbGaD
Thioridazine—Chlorpromazine—ALB—focal segmental glomerulosclerosis	0.000357	0.101	CrCbGaD
Thioridazine—HTR7—kidney—focal segmental glomerulosclerosis	0.000347	0.0518	CbGeAlD
Thioridazine—CYP2C8—kidney—focal segmental glomerulosclerosis	0.000295	0.0442	CbGeAlD
Thioridazine—CYP2E1—nephron tubule—focal segmental glomerulosclerosis	0.000283	0.0423	CbGeAlD
Thioridazine—CYP2E1—kidney—focal segmental glomerulosclerosis	0.000249	0.0372	CbGeAlD
Thioridazine—ADRA2A—cortex of kidney—focal segmental glomerulosclerosis	0.000248	0.037	CbGeAlD
Thioridazine—CYP2E1—cortex of kidney—focal segmental glomerulosclerosis	0.000242	0.0362	CbGeAlD
Thioridazine—HTR2A—kidney—focal segmental glomerulosclerosis	0.000216	0.0323	CbGeAlD
Thioridazine—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000197	0.0295	CbGeAlD
Thioridazine—HTR2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	6.65e-05	0.000846	CbGpPWpGaD
Thioridazine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	6.65e-05	0.000845	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	6.63e-05	0.000844	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	6.6e-05	0.000839	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.58e-05	0.000837	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.54e-05	0.000832	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	6.53e-05	0.00083	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—FN1—focal segmental glomerulosclerosis	6.52e-05	0.000829	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	6.51e-05	0.000828	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	6.51e-05	0.000828	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—NOS2—focal segmental glomerulosclerosis	6.45e-05	0.00082	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	6.43e-05	0.000818	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.39e-05	0.000813	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.38e-05	0.000812	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	6.34e-05	0.000806	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	6.33e-05	0.000805	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	6.32e-05	0.000803	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	6.3e-05	0.0008	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	6.21e-05	0.00079	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	6.21e-05	0.00079	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	6.2e-05	0.000788	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	6.18e-05	0.000786	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	6.05e-05	0.000769	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	6e-05	0.000764	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.99e-05	0.000762	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	5.98e-05	0.000761	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.96e-05	0.000758	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	5.91e-05	0.000752	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	5.91e-05	0.000751	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	5.9e-05	0.00075	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.85e-05	0.000743	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.84e-05	0.000743	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	5.8e-05	0.000738	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	5.79e-05	0.000736	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	5.76e-05	0.000732	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	5.68e-05	0.000722	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.66e-05	0.00072	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	5.65e-05	0.000718	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.63e-05	0.000716	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.63e-05	0.000716	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.6e-05	0.000712	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.5e-05	0.0007	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—LIPC—focal segmental glomerulosclerosis	5.48e-05	0.000697	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	5.45e-05	0.000693	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	5.43e-05	0.00069	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—ALB—focal segmental glomerulosclerosis	5.42e-05	0.000689	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	5.41e-05	0.000687	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.39e-05	0.000685	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	5.38e-05	0.000684	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	5.37e-05	0.000682	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.36e-05	0.000681	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	5.35e-05	0.000681	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.32e-05	0.000677	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	5.27e-05	0.00067	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	5.25e-05	0.000668	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.15e-05	0.000655	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.13e-05	0.000652	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.1e-05	0.000649	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—LIPC—focal segmental glomerulosclerosis	5.03e-05	0.00064	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.03e-05	0.00064	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	4.98e-05	0.000634	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.97e-05	0.000632	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.96e-05	0.00063	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.95e-05	0.00063	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.94e-05	0.000628	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.91e-05	0.000624	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	4.9e-05	0.000624	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	4.89e-05	0.000622	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.89e-05	0.000622	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	4.88e-05	0.000621	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.88e-05	0.00062	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.86e-05	0.000618	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.85e-05	0.000617	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.85e-05	0.000617	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	4.83e-05	0.000614	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	4.82e-05	0.000612	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.81e-05	0.000611	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.8e-05	0.000611	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	4.8e-05	0.000611	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.8e-05	0.000611	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.79e-05	0.000609	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.77e-05	0.000607	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.76e-05	0.000605	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.73e-05	0.000602	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.71e-05	0.000599	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.55e-05	0.000579	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.55e-05	0.000579	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.55e-05	0.000579	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.53e-05	0.000576	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.51e-05	0.000573	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	4.46e-05	0.000567	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.45e-05	0.000566	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.45e-05	0.000566	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.45e-05	0.000566	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.44e-05	0.000565	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—CTGF—focal segmental glomerulosclerosis	4.43e-05	0.000564	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.42e-05	0.000562	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.37e-05	0.000556	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.36e-05	0.000554	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	4.35e-05	0.000553	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.33e-05	0.00055	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.31e-05	0.000547	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.27e-05	0.000543	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.15e-05	0.000528	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.15e-05	0.000528	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.15e-05	0.000527	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.14e-05	0.000526	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.12e-05	0.000524	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.11e-05	0.000523	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.11e-05	0.000523	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.09e-05	0.00052	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.08e-05	0.000519	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.08e-05	0.000519	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.05e-05	0.000515	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.01e-05	0.00051	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4e-05	0.000509	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.92e-05	0.000499	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.91e-05	0.000498	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	3.88e-05	0.000494	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	3.83e-05	0.000487	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.8e-05	0.000483	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.8e-05	0.000483	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.8e-05	0.000483	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.74e-05	0.000475	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.73e-05	0.000474	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.72e-05	0.000473	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.67e-05	0.000467	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.67e-05	0.000467	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.66e-05	0.000465	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.65e-05	0.000464	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	3.57e-05	0.000454	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.56e-05	0.000453	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.55e-05	0.000451	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	3.54e-05	0.00045	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.54e-05	0.00045	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.54e-05	0.00045	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.53e-05	0.000449	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.49e-05	0.000444	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.49e-05	0.000444	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	3.43e-05	0.000436	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	3.42e-05	0.000435	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.4e-05	0.000432	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.39e-05	0.000431	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.37e-05	0.000429	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.35e-05	0.000426	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	3.35e-05	0.000425	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.27e-05	0.000416	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.22e-05	0.00041	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.21e-05	0.000408	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.19e-05	0.000405	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.17e-05	0.000403	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.16e-05	0.000402	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.16e-05	0.000402	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.16e-05	0.000402	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.15e-05	0.000401	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	3.15e-05	0.0004	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.13e-05	0.000397	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	3.12e-05	0.000397	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.11e-05	0.000396	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.1e-05	0.000395	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.08e-05	0.000391	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—LPL—focal segmental glomerulosclerosis	3.07e-05	0.000391	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.07e-05	0.00039	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.05e-05	0.000387	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.03e-05	0.000385	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	3.03e-05	0.000385	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.02e-05	0.000384	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.01e-05	0.000383	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.96e-05	0.000376	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.91e-05	0.00037	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.91e-05	0.00037	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.9e-05	0.000369	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.9e-05	0.000369	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.88e-05	0.000367	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.87e-05	0.000365	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	2.86e-05	0.000364	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.86e-05	0.000364	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.85e-05	0.000363	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.81e-05	0.000358	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.8e-05	0.000356	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.8e-05	0.000356	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.72e-05	0.000346	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.72e-05	0.000346	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.68e-05	0.000341	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.67e-05	0.00034	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	2.66e-05	0.000339	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	2.66e-05	0.000338	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.65e-05	0.000337	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.63e-05	0.000335	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—AGT—focal segmental glomerulosclerosis	2.63e-05	0.000334	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.63e-05	0.000334	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.58e-05	0.000328	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.58e-05	0.000328	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.47e-05	0.000314	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.46e-05	0.000312	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.43e-05	0.000309	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.43e-05	0.000308	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.42e-05	0.000308	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.42e-05	0.000308	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.39e-05	0.000304	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.39e-05	0.000303	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.38e-05	0.000303	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	2.37e-05	0.000301	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.34e-05	0.000298	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.33e-05	0.000296	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	2.27e-05	0.000289	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.23e-05	0.000284	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.21e-05	0.000281	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	2.2e-05	0.000279	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	2.18e-05	0.000277	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	2.16e-05	0.000275	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.09e-05	0.000265	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.06e-05	0.000261	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	2.03e-05	0.000258	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.02e-05	0.000257	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.02e-05	0.000257	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—ALB—focal segmental glomerulosclerosis	2.02e-05	0.000256	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2e-05	0.000254	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.99e-05	0.000254	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.99e-05	0.000253	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.98e-05	0.000252	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	1.87e-05	0.000237	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	1.85e-05	0.000235	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	1.85e-05	0.000235	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.84e-05	0.000234	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.79e-05	0.000228	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.78e-05	0.000227	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	1.74e-05	0.000222	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.72e-05	0.000219	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.71e-05	0.000217	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	1.58e-05	0.000201	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.57e-05	0.0002	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	1.56e-05	0.000198	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.55e-05	0.000197	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.55e-05	0.000197	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.52e-05	0.000193	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.52e-05	0.000193	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.48e-05	0.000188	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.47e-05	0.000187	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	1.43e-05	0.000182	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	1.42e-05	0.00018	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.41e-05	0.000179	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.41e-05	0.000179	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.3e-05	0.000165	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.28e-05	0.000162	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.27e-05	0.000162	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.25e-05	0.000159	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.25e-05	0.000159	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	1.21e-05	0.000154	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.16e-05	0.000148	CbGpPWpGaD
